Autologous Stem Cell Transplantation Clinical Trials

16 clinical trials for Autologous Stem Cell Transplantation across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• CIBMTR Research Database — RECRUITING
• Olanzapine 2.5 vs 5 mg in Quadruplet Nausea/Vomiting Prophylaxis Before High-Dose Melphalan — RECRUITING · PHASE3
• Protocol for a Research Sample Repository for Hematopoietic Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries — RECRUITING
• Dara-RVd Induction for Newly Diagnosed Multiple Myeloma With Autologous Stem Cell Transplantation — WITHDRAWN · PHASE2
• Clinical Study of CAR-T Cell Therapy Following ASCT for R/R B-cell Non-Hodgkin's Lymphoma — TERMINATED · PHASE2
• Upfront Autologous HSCT Versus Immunosuppression in Early Diffuse Cutaneous Systemic Sclerosis — COMPLETED · PHASE4
• Daratumumab-containing Induction Effects on Stem Cells Mobilization, colLection and Engraftment in Newly Diagnosed Multiple MyelomA Patients. — COMPLETED
• Autologous Stem Cell Transplantation for Progressive Systemic Sclerosis — COMPLETED · PHASE2
• Modified BEAM Regimen for T Cell Lymphoma Underwent ASCT — OTHER · NA
• Pedometer Activity Monitoring After ASCT — COMPLETED · PHASE2
• Microtransplantation Versus Auto-SCT in ≥PR Multiple Myeloma Patients — OTHER · NA
• Mozobil for Autologous Stem Cell Mobilization — COMPLETED · PHASE2
• NOX-A12 First-in-human (FIH) Study — COMPLETED · PHASE1
• AMD3100 (Plerixafor) With G-CSF in Poor Mobilizing Adult Patients Who Previously Failed Hematopoietic Stem Cell (HSC) Collection/Attempts — COMPLETED · PHASE2
• Stem Cell Harvesting Using GCSF Plus Plerxiafor, in First -Line, for Heavily Pre- Treated Pediatric Oncology Patients. — OTHER · PHASE4
• NOX-A12 to Mobilize Stem Cells in Healthy Volunteers - A Single-center, Single Dose, Open Label, Dose Escalation Study of Intravenous NOX-A12 in up to 42 Healthy Subjects — OTHER

Refine this search